Larimar Therapeutics Inc (LRMR) returns
Larimar Therapeutics returns over 10 years
$1,000 invested in Larimar Therapeutics ten years ago was worth $67.27 at the close on October 30, 2026, with dividends reinvested: an average return of -23.7% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -22.7% | — | $773.08 | -0.9% |
| 3 months | -35.4% | — | $645.75 | +2.1% |
| Year to date | -35.2% | — | $648.29 | +11.7% |
| 1 year | -38.9% | — | $611.39 | +12.4% |
| 3 years | -15.4% | -5.4% | $845.89 | +88.5% |
| 5 years | -79.3% | -27.0% | $206.69 | +76.0% |
| 10 years | -93.3% | -23.7% | $67.27 | +316.6% |
Larimar Therapeutics return by calendar year
| Year | LRMR | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -35.2% | +11.7% | -46.9% |
| 2025 | -1.6% | +17.7% | -19.3% |
| 2024 | -14.9% | +24.9% | -39.8% |
| 2023 | +10.2% | +26.2% | -16.0% |
| 2022 | -61.7% | -18.2% | -43.6% |
| 2021 | -49.6% | +28.7% | -78.3% |
| 2020 | +60.7% | +18.4% | +42.4% |
| 2019 | -77.6% | +31.2% | -108.8% |
| 2018 | +7.1% | -4.6% | +11.7% |
| 2017 | +45.3% | +21.7% | +23.6% |
| 2016 | -49.4% | +12.0% | -61.4% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Larimar Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.